PubMedCrossRef Seventeen. Lorber N. GLP-1 receptor agonists: results about aerobic risk decrease. Cardiovasc Ther. This year. [Epub in advance of print]. 20. Gaspari Capital t, Welungoda My partner and i, Widdop Regarding, et aussi 's. The particular GLP-1 receptor agonist liraglutide prevents growth of vascular disease via effects in atherogenesis, back plate steadiness and also endothelial purpo